News | February 14, 2011

Cerebral Oximetry Identifies Patient Risk Levels Prior to Cardiac Surgery

February 14, 2011 – Cardiac surgeons now have a simple, noninvasive way to assess patients at risk for poor outcomes prior to surgery with the Invos Cerebral/Somatic Oximeter, from Covidien.

New evidence, published in Anesthesiology, showed that cerebral regional oxygen saturation (rSO2) values, which reflect brain oxygenation, measured prior to cardiac surgery, were independent predictors of 30-day and one-year morbidity and mortality. This is the first adult study to link decreased preoperative cerebral rSO2 with postoperative morbidity and mortality.

“Our finding suggests that low, presurgical cerebral rSO2 might serve as a refined physiological marker for preoperative risk stratification in cardiac patients,” said lead investigator Matthias Heringlake, M.D., Universitaet zu Luebeck, Germany. “This enhanced assessment may also enable physicians to proactively consider adding or tailoring care therapies per patient.”

The study assessed cerebral rSO2 readings from the Invos system in 1,178 adult patients about to undergo on-pump cardiac surgery. The analysis showed that baseline cerebral rSO2 values less than or equal to 50 percent were independent predictors of 30-day and one-year morbidity and mortality.

It also showed a statistically significant correlation between cerebral rSO2 values and traditional measures of cardiopulmonary function, such as left ventricular ejection fraction, pro-B natriuretic peptide and kidney filtration rate, among others.

“Consistent with these new findings, earlier studies showed that rSO2 not only reflects cerebral oxygenation, but also a patient’s overall cardiopulmonary function and systemic oxygen needs,” said John M. Murkin, M.D., FRCPC, of the Schulich School of Medicine at the University of Western Ontario, whose earlier trial showed a connection between adequate rSO2 and improved patient outcomes. “If non-cardiac researchers confirm similar benefits of cerebral rSO2 monitoring, then it could be employed as a simple, sensitive and noninvasive way to enhance the preoperative risk assessment of noncardiac patients as well.”

Other recent research found that cerebral rSO2 monitoring provides a first alert to changes in oxygenation that could potentially lead to an adverse patient outcome. Cerebral oximetry data were registered from January 2008 through December 2009 in the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database. Initial findings were released in July 2010 and showed that in nearly one in four (23 percent) cardiac surgery procedures (n=36,548) “cerebral oximetry provided the first indication of a technical problem or physiologic change that could potentially lead to an adverse patient outcome.”

“Oxygen deficiencies that lead to neurological injury or other complications often have no initial outward signs,” said Scott Kelley, M.D., vice president, medical affairs, respiratory and monitoring solutions, Covidien. “They can brew silently and go undetected until damage has already been done. Use of preoperative rSO2 could augment anesthesiologists’ already robust practices for vigilance and patient safety.”

For more information: www.covidien.com

Related Content

CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
Wearable monitors create patient generated health data, PGHD, that can help prevent acute care episodes in heart failure.

Wearable monitoring devices may offer a new tool to help prevent acute care episodes in heart failure.

Feature | Heart Failure| July 25, 2017 | Lola Koktysh
Despite their best efforts, many patients tend to develop heart failure after an acute event (e.g., a heart attack or
Sponsored Content | Videos | Peripheral Artery Disease (PAD)| July 25, 2017
This video case study, provided by Gore Medical, is titled "Tackling Complex Cases in Dialysis Access," by John Ross,
Sponsored Content | Videos | Cardiovascular Surgery| July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients
News | Heart Failure| July 14, 2017
A review appearing in the July 18 issue of the Journal of the American College of Cardiology (JACC) discusses current...
Sponsored Content | Videos | Heart Failure| July 13, 2017
William Abraham, M.D., director of the Division of Cardiovascular Medicine at The Ohio State University Wexner Medica
monitoring a heart failure patient's chest fluid buildup with remote monitoring using the SensiVest

A heart failure patient wearing the SensiVest remote monitoring system for a two-minute a day assessment. 

News | Heart Failure| July 13, 2017
July 13, 2017 — About 5.7 million adults in the U.S.
Ohio State Investigating High-Tech Vest for At-Home Heart Failure Management
News | Heart Failure| June 28, 2017
Doctors at The Ohio State University Richard M. Ross Heart Hospital are testing a high-tech vest that measures fluid...
First Canadian Patient Implanted With CardioMEMS Heart Failure Sensor
News | Heart Failure| June 23, 2017
In a Canadian first, a medical team has implanted the wireless CardioMEMS HF device inside a heart failure patient. The...
Overlay Init